These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15700180)

  • 1. Frontal-temporal regional differences in brain energy metabolism and mitochondrial function using
    Lopez FV; O'Shea A; Huo Z; DeKosky ST; Trouard TP; Alexander GE; Woods AJ; Bowers D
    Geroscience; 2024 Jun; 46(3):3185-3195. PubMed ID: 38225480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of
    Jett S; Boneu C; Zarate C; Carlton C; Kodancha V; Nerattini M; Battista M; Pahlajani S; Williams S; Dyke JP; Mosconi L
    Front Aging Neurosci; 2023; 15():1183228. PubMed ID: 37273652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative Changes in the Brains of the 5xFAD Alzheimer's Disease Model Mice Investigated by High-Field and High-Resolution Magnetic Resonance Imaging and Multi-Nuclei Magnetic Resonance Spectroscopy.
    Yoo CH; Kim J; Baek HM; Chang KA; Choe BY
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex and menopause impact
    Jett S; Dyke JP; Andy C; Schelbaum E; Jang G; Boneu Yepez C; Pahlajani S; Diaz I; Diaz Brinton R; Mosconi L
    Sci Rep; 2022 Dec; 12(1):22087. PubMed ID: 36543814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.
    Song T; Song X; Zhu C; Patrick R; Skurla M; Santangelo I; Green M; Harper D; Ren B; Forester BP; Öngür D; Du F
    Ageing Res Rev; 2021 Dec; 72():101503. PubMed ID: 34751136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate Brain Energy Metabolism and Cognition in Alzheimer's Disease: A Spectroscopy Study Using Whole-Brain Volume-Coil
    Das N; Ren J; Spence J; Chapman SB
    Front Neurosci; 2021; 15():641739. PubMed ID: 33889067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Parieto-Occipital Brain Energy Phosphate Metabolism and Cognition Using
    Das N; Ren J; Spence JS; Rackley A; Chapman SB
    Front Aging Neurosci; 2020; 12():222. PubMed ID: 33005142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil.
    Fonseca LM; Haddad GG; Mattar GP; Oliveira MC; Simon SS; Guilhoto LM; Busatto GF; Zaman S; Holland AJ; Hoexter MQ; Bottino CM
    Braz J Psychiatry; 2019; 41(3):225-233. PubMed ID: 30365671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.
    Rijpma A; van der Graaf M; Lansbergen MM; Meulenbroek O; Cetinyurek-Yavuz A; Sijben JW; Heerschap A; Olde Rikkert MGM
    Alzheimers Res Ther; 2017 Jul; 9(1):51. PubMed ID: 28747210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.
    Talib LL; Hototian SR; Joaquim HP; Forlenza OV; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):701-6. PubMed ID: 25920742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?
    Veitinger M; Varga B; Guterres SB; Zellner M
    Acta Neuropathol Commun; 2014 Jun; 2():65. PubMed ID: 24934666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet biomarkers in Alzheimer's disease.
    Talib LL; Joaquim HP; Forlenza OV
    World J Psychiatry; 2012 Dec; 2(6):95-101. PubMed ID: 24175175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.
    Gattaz WF; Talib LL; Schaeffer EL; Diniz BS; Forlenza OV
    J Neural Transm (Vienna); 2014 Feb; 121(2):193-200. PubMed ID: 24036895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.
    Schaeffer EL; Forlenza OV; Gattaz WF
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):37-51. PubMed ID: 18853146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.
    Schaeffer EL; Gattaz WF
    Psychopharmacology (Berl); 2008 May; 198(1):1-27. PubMed ID: 18392810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR spectroscopy in neurodegenerative disease.
    Martin WR
    Mol Imaging Biol; 2007; 9(4):196-203. PubMed ID: 17279431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease.
    Forlenza OV; Schaeffer EL; Gattaz WF
    J Neural Transm (Vienna); 2007 Feb; 114(2):231-8. PubMed ID: 17131232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.
    Forlenza OV; Wacker P; Nunes PV; Yacubian J; Castro CC; Otaduy MC; Gattaz WF
    Psychopharmacology (Berl); 2005 Jul; 180(2):359-65. PubMed ID: 15700180
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.